Enhertu could reach $18M sales in Q1: Daiichi U.S. CEO by Angus Liu Monday, February 10, 2020 Thanks to clear clinical benefits and two well-prepared sales team, Enhertu could be looking at $18 million in sales in Q1, Daiichi U.S. chief said.
Daiichi unveils CEO successor amid oncology refocus by Angus Liu Friday, March 29, 2019 Daiichi is transitioning from CV and metabolic diseases to oncology, and it says now is the right time for a new CEO to take the helm.
